Communications

Weekly Student Communication (TUG + SPS) | March 24, 2021

WPU Student community, 

A reminder that next week, April 1 + 2nd there will be no classes! Enjoy your break and please continue to follow the health and safety protocols: wear a mask, social distancing and wash your hands. It’s our best protection.

Stay abreast of when you will be eligible for the COVID vaccine. Currently Group 4 is eligible and on April 7th, people in close group living settings (on-campus housing) will qualify for registration of the vaccine. 

Get Ready: When you are eligible for COVID vaccination; make sure you take the time to schedule your appointment/s.

Get Vaccinated: Let’s all do our part and get vaccinated (whenever it is available to you). At this time, the University is not an approved vaccination site, please be sure to click here to find local sites.

Get Happy: As more and more individuals are vaccinated, there will be greater opportunities for getting back to normal. 

COVID Corner with Dr. Scott, WPU University Physician

Q: Which COVID-19 Vaccine Should You Get? 

A: The three available vaccines (Pfizer, Moderna, and Johnson & Johnson) are remarkably effective by all vaccine standards.  Both the Pfizer and Moderna vaccines use a new “mRNA technology” which replicates a portion of the viral exterior protein and sets off an immune response against any subsequent virus with that protein on its surface. The Johnson & Johnson vaccine employs a more traditional “viral vector technology” which uses a modified version of a different, harmless virus to stimulate the body’s immune response. The 95% effectiveness of the Pfizer and Moderna vaccines in eliminating clinical disease is truly mind boggling.  At first glance, this would appear to make the Johnson & Johnson vaccine substantially less effective at 66%.  But that would not be a fair comparison. The 95% effectiveness of the mRNA vaccines refers to prevention of clinically apparent or symptomatic disease. In other words, no culturing was done to identify asymptomatic positives. The 66% figure is how effective the Johnson & Johnson vaccine  was at preventing laboratory confirmed COVID-19 infections, so asymptomatic positives counted against its efficacy numbers.  It’s a little bit of an “apples and oranges” comparison since different outcomes were being compared.

Although Pfizer and Moderna completed their clinical trials before the emergence of variants, Johnson & Johnson did theirs after variant strains of the COVID-19 virus were discovered.. When you analyze Johnson & Johnson’s data further, not a single recipient of the vaccine was hospitalized with COVID-19 (after removing the persons who became infected before the immunization had time to take effect.)  So, in essence, the Johnson & Johnson vaccine took on a highly lethal viral infection and its variants and made it no more severe than the common cold.  That is also a mind boggling accomplishment!  

So here’s the bottom line: Take whichever vaccine you are offered. You can’t go wrong!

Ask the Expert: Submit your COVID related health questions to Dr. Scott and questions will be answered in future communications. SUBMIT YOUR QUESTIONS

We will continue to send out weekly emails to include updates and highlights of timely information to ensure a successful semester. These communications will continue to be added to covid.peace.edu/communications.

In Peace,

Office of Communications